• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.
    All News #Library
    Others

    FDA to Revise ADHD Drug Labels Over Weight Loss Risk in Kids

    REUTERS

    US Says It Halts Healthcare Fraud Schemes Worth Nearly $15 B

    REUTERS

    Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

    PR NEWSWIRE

    EUROAPI sells Haverhill site to Particle Dynamics

    PRESS RELEASE

    Hikma Pharmaceuticals Usa Invests $1 Billion in US Expansion

    FIERCE PHARMA

    Medac Unveils New Methotrexate Data For Arthritis At EULAR 2025

    PRESS RELEASE

    Changes to the Roche Enlarged Corporate Executive Committee

    GLOBENEWSWIRE

    Addex Leads CHF 2M Investment in Stalicla for Precision Medicine

    GLOBENEWSWIRE

    Press release: Availability of the Q2 2025 Aide mémoire

    PRESS RELEASE

    Nicox: Last Patient Completes NCX 470 Denali Phase 3 Trial

    GLOBENEWSWIRE

    AB Science updates loan repayment terms with creditors

    GLOBENEWSWIRE

    Syngenta to Lead in Biologicals, Expanding Solutions for Farmers

    BUSINESSWIRE

    Torrent Pharma To Acquire JB Chemicals Stake From KKR

    BUSINESSWIRE

    Zambon Launches Intravenous Formulation of Fluimucil

    INDPHARMAPOST

    Neuland Labs Gets EIR from USFDA for Pashamylaram Unit 2

    INDPHARMAPOST

    Shukra Pharmaceuticals receives LoA from RMSCL

    INDPHARMAPOST

    Lilly, Innovent`s Mazdutide Nabs First-In-Class Nod in China

    FIERCE PHARMA

    UCB`s Fintepla shows potential to treat a 3rd epilepsy disorder

    FIERCE PHARMA

    US Senator Probes GSK`s Halt of Children`s Asthma Inhaler

    REUTERS

    Gilead Shares Rise After Top Court Ruling on Preventive Coverage

    REUTERS

    Eton Pharmaceuticals Added to Russell 2000® and 3000® Indices

    GLOBENEWSWIRE

    Pharvaris to Present Deucrictibant Data at 2025 US HAEA Summit

    GLOBENEWSWIRE

    Tango Announces First Patient Dosed in Phase 1/2 Trial of TNG462

    GLOBENEWSWIRE

    BioCryst Sells European ORLADEYO Business to Neopharmed Gentili

    GLOBENEWSWIRE

    Foxo Technologies Sets New Preferred Stock for M&A Use

    GLOBENEWSWIRE

    Allarity Therapeutics Doses Second Patient in Stenoparib Phase 2

    GLOBENEWSWIRE

    Lyra Therapeutics Announces $15M Offering Under Nasdaq Rules

    GLOBENEWSWIRE

    CorMedix Inc. Prices Public Offering of Common Stock

    GLOBENEWSWIRE

    Autonomix Gets U.S. Patent for Catheter Platform Tech

    GLOBENEWSWIRE

    Calidi Biotherapeutics Announces Shareholder Letter from CEO

    GLOBENEWSWIRE

    Jupiter Neurosciences Unveils Nugevia™ GLO for Skin Health

    GLOBENEWSWIRE

    Helius Medical Technologies Announces Reverse Stock Split

    GLOBENEWSWIRE

    Results of Annual General Meeting

    GLOBENEWSWIRE

    Clearmind Medicine Expands Global Alcohol Use Disorder Trial

    GLOBENEWSWIRE

    Channel Therapeutics Announces Reverse Common Stock Split

    GLOBENEWSWIRE

    INmune Bio, Inc. Announces $19M Direct Offering on Nasdaq

    GLOBENEWSWIRE

    Xenon Joins the Russell 3000® and Russell 2000® Indexes

    GLOBENEWSWIRE

    Titan Pharmaceuticals Announces $600,000 Stock Placement

    GLOBENEWSWIRE

    Pliant Therapeutics Provides Update on BEACON-IPF

    GLOBENEWSWIRE

    Information on The Total Number of Voting Rights and Shares

    GLOBENEWSWIRE

    Ahsan Ashraf Joins Jaylen Brown as Hapbee Investor and Executive

    GLOBENEWSWIRE

    VitalHub Announces AGM Results

    GLOBENEWSWIRE

    Ontrak Health Announces Pricing of $4 Million Public Offering

    BUSINESSWIRE

    Vetter Begins New Clinical Site Construction with Ceremony

    BUSINESSWIRE

    PRD Therapeutics Starts First Human Study for PRD001

    BUSINESSWIRE

    Foldax Announces Positive One-Year Data on TRIA Mitral Valve

    BUSINESSWIRE

    Metabolics Pharma: ENT-03 Shows Weight Loss in Animal Model

    BUSINESSWIRE

    Exicure, Inc. Reports First Quarter 2025 Financial Results

    BUSINESSWIRE

    ZYUS Life Sciences Announces Closing of Unit Offering

    BUSINESSWIRE

    SINOVAC Board Wins Lawsuit in Hong Kong

    BUSINESSWIRE

    Brent H. Zettl Updates Holdings in ZYUS Life Sciences Corporation

    BUSINESSWIRE

    SMS Pharma Completes USFDA Audit of Central Lab Services

    INDPHARMAPOST

    Star Health, Medi Assist Partner to Drive AI in Claims

    INDPHARMAPOST

    UCB Reports Positive Ph3 GEMZ Results in CDKL5 Disorder

    PR NEWSWIRE

    Navamedic : OraFid® Approved as Primary Package

    PR NEWSWIRE

    GC Biopharma USA Showcases IVIG Safety Approach at 2025 CIS Meeti

    PR NEWSWIRE

    Cindy Eckert Wins Ernst & Young Entrepreneur Of The Year® 2025

    PR NEWSWIRE

    Mabwell License Agreement Albipagrastim to Qilu Pharmaceutical

    PR NEWSWIRE

    Biovica International AB - Annual Report for the Financial Year

    ACCESSWIRE

    IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update

    ACCESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.